Correlation Between Sprott Focus and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Sprott Focus and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprott Focus and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprott Focus Trust and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Sprott Focus and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprott Focus with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprott Focus and Chugai Pharmaceutical.
Diversification Opportunities for Sprott Focus and Chugai Pharmaceutical
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sprott and Chugai is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sprott Focus Trust and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Sprott Focus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprott Focus Trust are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Sprott Focus i.e., Sprott Focus and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between Sprott Focus and Chugai Pharmaceutical
Given the investment horizon of 90 days Sprott Focus is expected to generate 1.36 times less return on investment than Chugai Pharmaceutical. But when comparing it to its historical volatility, Sprott Focus Trust is 2.78 times less risky than Chugai Pharmaceutical. It trades about 0.1 of its potential returns per unit of risk. Chugai Pharmaceutical Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 2,217 in Chugai Pharmaceutical Co on December 28, 2024 and sell it today you would earn a total of 114.00 from holding Chugai Pharmaceutical Co or generate 5.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sprott Focus Trust vs. Chugai Pharmaceutical Co
Performance |
Timeline |
Sprott Focus Trust |
Chugai Pharmaceutical |
Sprott Focus and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sprott Focus and Chugai Pharmaceutical
The main advantage of trading using opposite Sprott Focus and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprott Focus position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.Sprott Focus vs. MFS Investment Grade | Sprott Focus vs. Eaton Vance National | Sprott Focus vs. Nuveen California Select | Sprott Focus vs. Federated Premier Municipal |
Chugai Pharmaceutical vs. Scilex Holding | Chugai Pharmaceutical vs. Merck Company | Chugai Pharmaceutical vs. Johnson Johnson | Chugai Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
CEOs Directory Screen CEOs from public companies around the world |